Duchenne Muscular Dystrophy

BioMarin CEO Angers Sarepta CEO With Slides Comparing Trial Data
WSJ Pharmalot
Sat, 01/17/15 - 11:01 am
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biotech Rivalry Gets Nasty in Mudslinging Battle Over Data
Bloomberg
Thu, 01/15/15 - 09:28 pm
Sarepta Therapeutics
Biomarin
Duchenne Muscular Dystrophy
BioMarin CEO Sees Big Future For Prosensa Drug
Investors.com
Wed, 12/24/14 - 08:58 am
Biomarin
Prosensa
drisapersen
Duchenne Muscular Dystrophy
Pfizer bets on Duchenne MD treatment
Medical Marketing and Media
Thu, 12/18/14 - 04:30 pm
Pfizer
Duchenne Muscular Dystrophy
Translarna
A ‘Strange Back and Forth’ Between Sarepta and the FDA
WSJ Pharmalot
Fri, 10/31/14 - 02:13 pm
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
Sarepta timeline delayed on muscular dystrophy drug
CNBC
Mon, 10/27/14 - 08:51 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study
The Chairman's Blog
Mon, 10/13/14 - 04:09 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Prosensa heads to the FDA with its once-failed DMD treatment
Fierce Biotech
Fri, 10/10/14 - 11:41 am
Prosensa
FDA
Duchenne Muscular Dystrophy
drisapersen
Prosensa declares progress on drug target for Duchenne
Pharmaphorum
Thu, 09/25/14 - 09:46 am
Prosensa
Duchenne Muscular Dystrophy
Prosensa picks up $7M to speed up DMD development
Fierce Biotech
Tue, 08/12/14 - 05:45 pm
Duchenne Muscular Dystrophy
Prosensa
Most popular news headlines for Thursday, August 7 2014
CP Wire
Fri, 08/8/14 - 08:14 am
Allergan
M&A
Valeant Pharmaceuticals
tax inversions
PTC Therapeutics
Duchenne Muscular Dystrophy
ebola virus
Tekmira Pharmaceuticals
Most popular news headlines for Thursday, August 7 2014
Fri, 08/8/14 - 08:12 am
Allergan
M&A
Valeant Pharmaceuticals
tax inversions
PTC Therapeutics
Duchenne Muscular Dystrophy
ebola virus
Tekmira Pharmaceuticals
Why a bigger deal hasn't been made of the world's first approval of a Duchenne drug
Bizjournals.com
Thu, 08/7/14 - 09:45 am
Duchenne Muscular Dystrophy
drug approvals
PTC Therapeutics
Translarna
CEO Reasserts Control Over Biotech Developer of Muscular Dystrophy Drug
Bloomberg/Businessweek
Fri, 08/1/14 - 09:12 am
Pharma CEOs
Duchenne Muscular Dystrophy
eteplirsen
Chris Garabedian
Stop Squabbling, Mom Tells Troubled Biotech: 'Just Get My Kid the Drug'
Bloomberg/Businessweek
Mon, 07/28/14 - 12:19 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Latest Sarepta Study Update Shows Greater Decline in Walking Ability
TheStreet.com
Thu, 07/10/14 - 08:51 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
What You Need to Know About PTC Therapeutics' Promising DMD Drug
Motley Fool
Thu, 06/5/14 - 11:19 am
Duchenne Muscular Dystrophy
PTC Therapeutics
eteplirsen
Prosensa to Seek U.S. Approval for DMD Drug
TheStreet.com
Tue, 06/3/14 - 11:00 am
Duchenne Muscular Dystrophy
Prosensa
drisapersen
Sarepta gearing for potential 2015 launch of eteplirsen, says Piper Jaffray
The Fly on the Wall
Thu, 05/22/14 - 11:54 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta's Still a Gamble, Even With FDA Reversal
Motley Fool
Fri, 04/25/14 - 08:31 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen

Pages